JP7609795B2 - 新規選択マーカーを含む細胞株及びタンパク質製造のためのそれらの使用 - Google Patents

新規選択マーカーを含む細胞株及びタンパク質製造のためのそれらの使用 Download PDF

Info

Publication number
JP7609795B2
JP7609795B2 JP2021556438A JP2021556438A JP7609795B2 JP 7609795 B2 JP7609795 B2 JP 7609795B2 JP 2021556438 A JP2021556438 A JP 2021556438A JP 2021556438 A JP2021556438 A JP 2021556438A JP 7609795 B2 JP7609795 B2 JP 7609795B2
Authority
JP
Japan
Prior art keywords
cell line
dhodh
sequence
gene
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021556438A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526497A5 (https=
JP2022526497A (ja
Inventor
ブリュノ・ルイ・デュマ
モハメド・ナビル・ルニス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JP2022526497A publication Critical patent/JP2022526497A/ja
Publication of JP2022526497A5 publication Critical patent/JP2022526497A5/ja
Application granted granted Critical
Publication of JP7609795B2 publication Critical patent/JP7609795B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002Dihydroorotate dehydrogenase (1.3.5.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2021556438A 2019-03-19 2020-03-19 新規選択マーカーを含む細胞株及びタンパク質製造のためのそれらの使用 Active JP7609795B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19305331.1 2019-03-19
EP19305331 2019-03-19
PCT/EP2020/057583 WO2020188021A1 (en) 2019-03-19 2020-03-19 Novel selection marker-comprising cell line and uses thereof for protein production

Publications (3)

Publication Number Publication Date
JP2022526497A JP2022526497A (ja) 2022-05-25
JP2022526497A5 JP2022526497A5 (https=) 2023-03-06
JP7609795B2 true JP7609795B2 (ja) 2025-01-07

Family

ID=66001151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021556438A Active JP7609795B2 (ja) 2019-03-19 2020-03-19 新規選択マーカーを含む細胞株及びタンパク質製造のためのそれらの使用

Country Status (14)

Country Link
US (1) US12529071B2 (https=)
EP (1) EP3942054A1 (https=)
JP (1) JP7609795B2 (https=)
KR (1) KR20210141511A (https=)
CN (1) CN113811615B (https=)
AU (1) AU2020242966B2 (https=)
BR (1) BR112021018124A2 (https=)
CA (1) CA3134116A1 (https=)
IL (1) IL286419A (https=)
MX (1) MX2021011303A (https=)
SG (1) SG11202110105UA (https=)
TW (1) TWI881970B (https=)
WO (1) WO2020188021A1 (https=)
ZA (1) ZA202106718B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI912369B (zh) * 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007132949A1 (ja) 2006-05-16 2007-11-22 National Institute Of Advanced Industrial Science And Technology タンパク質の高分泌生産方法
WO2012027533A1 (en) 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods
US20170335292A1 (en) 2014-10-23 2017-11-23 Sanofi Novel Selection Marker for Cell Transfection and Protein Production

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
RU2556816C1 (ru) 2014-03-12 2015-07-20 Открытое акционерное общество "Фармацевтический импорт, экспорт" (ОАО "Фармимэкс") Штамм клеток яичников китайского хомячка - продуцент рекомбинантного антитела против фактора некроза опухоли альфа человека
US11096934B2 (en) 2015-09-01 2021-08-24 The Broad Institute, Inc. Compounds and methods useful for treating or preventing hematological cancers
US10736911B2 (en) * 2015-12-29 2020-08-11 The Board Of Trustees Of The Leland Stanford Junior University Use of a DHODH inhibitor in combination with an inhibitor of pyrimidine salvage
CN109777837A (zh) 2018-12-26 2019-05-21 首都医科大学 一种利用CRISPR/Cas9系统构建致死基因全身性敲除小鼠模型的方法
TWI912369B (zh) 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007132949A1 (ja) 2006-05-16 2007-11-22 National Institute Of Advanced Industrial Science And Technology タンパク質の高分泌生産方法
WO2012027533A1 (en) 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods
US20170335292A1 (en) 2014-10-23 2017-11-23 Sanofi Novel Selection Marker for Cell Transfection and Protein Production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BAJZIKOVA et al.,Cell Metabolism,2019年,Vol. 29, No. 2,p.399-416,DOI:10.1016/j.cmet.2018.10.014

Also Published As

Publication number Publication date
AU2020242966A1 (en) 2021-10-21
CN113811615B (zh) 2025-11-11
TW202102669A (zh) 2021-01-16
CA3134116A1 (en) 2020-09-24
TWI881970B (zh) 2025-05-01
ZA202106718B (en) 2023-04-26
EP3942054A1 (en) 2022-01-26
MX2021011303A (es) 2021-10-22
US12529071B2 (en) 2026-01-20
AU2020242966B2 (en) 2025-09-25
BR112021018124A2 (pt) 2021-11-16
CN113811615A (zh) 2021-12-17
KR20210141511A (ko) 2021-11-23
IL286419A (en) 2021-10-31
WO2020188021A1 (en) 2020-09-24
US20220177909A1 (en) 2022-06-09
SG11202110105UA (en) 2021-10-28
JP2022526497A (ja) 2022-05-25

Similar Documents

Publication Publication Date Title
JP5432117B2 (ja) 宿主細胞中の組換えタンパク質の発現を増進するための組換え発現ベクター要素(rEVE)
US12203103B2 (en) Selection marker for cell transfection and protein production
JP7609795B2 (ja) 新規選択マーカーを含む細胞株及びタンパク質製造のためのそれらの使用
EP4214308B1 (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production
RU2820830C2 (ru) Линия клеток, содержащая новый маркер отбора, и ее применение для продуцирования белков
RU2849601C1 (ru) Получение рекомбинантной линии клеток китайского хомячка, характеризующейся высоким продуцированием, для продуцирования терапевтических белков
HK40096091A (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production
HK40096091B (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240912

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241219

R150 Certificate of patent or registration of utility model

Ref document number: 7609795

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150